Home > Compound List > Product Information
Combretastatin A4_Molecular_structure_CAS_117048-59-6)
Click picture or here to close

Combretastatin A4

Catalog No. C7744 Name Sigma Aldrich
CAS Number 117048-59-6 Website http://www.sigmaaldrich.com
M. F. C18H20O5 Telephone 1-800-521-8956
M. W. 316.3484 Fax
Purity ≥98% (HPLC) Email
Storage Chembase ID: 126674

SYNONYMS

IUPAC name
2-methoxy-5-[2-(3,4,5-trimethoxyphenyl)ethenyl]phenol
IUPAC Traditional name
combretastatin A-4
Synonyms
CA4
2-Methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenol
1-(3,4,5-Trimethoxyphenyl)-2-(3′-hydroxy-4′-methoxyphenyl) ethane 3,4,5-trimethoxy-3′-hydroxy-4′-methoxystilbene

DATABASE IDS

CAS Number 117048-59-6
MDL Number MFCD03453309

PROPERTIES

Empirical Formula (Hill Notation) C18H20O5
Purity ≥98% (HPLC)
Apperance off-white powder
Solubility DMSO: >10 mg/mL
GHS Pictograms GHS05
GHS Pictograms GHS06
GHS Signal Word Danger
GHS Hazard statements H301-H311-H318-H331
European Hazard Symbols Toxic Toxic (T)
MSDS Link Download
Personal Protective Equipment Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges
GHS Precautionary statements P261-P280-P301 + P310-P305 + P351 + P338-P311
RID/ADR UN 2811 6.1/PG 3
Risk Statements 23/24/25-41
Safety Statements 26-36/37-39-45
Storage Temperature -20°C
Hazard Class 6.1
UN Number 2811
Packing Group 3
German water hazard class 2

DETAILS

Description (English)
Biochem/physiol Actions
Combretastatin A4 is a vascular disrupting agent (VDA) that targets tumor vasculature to inhibit angiogenesis. It inhibits tubulin polymerization at the colchicine-binding site of beta-tubulin. It has antitumor activity by inhibiting AKT function in human gastric cells. The inhibited AKT activation causes decreased cell proliferation, cell cycle arrest, and reduced in vitro migration/invasiveness and in vivo metastatic ability. Combretastatin A4 is a natural stilbenoid phenol.
Description (简体中文)
Biochem/physiol Actions
Combretastatin A4 is a vascular disrupting agent (VDA) that targets tumor vasculature to inhibit angiogenesis. It inhibits tubulin polymerization at the colchicine-binding site of beta-tubulin. It has antitumor activity by inhibiting AKT function in human gastric cells. The inhibited AKT activation causes decreased cell proliferation, cell cycle arrest, and reduced in vitro migration/invasiveness and in vivo metastatic ability. Combretastatin A4 is a natural stilbenoid phenol.

REFERENCES